9
Participants
Start Date
January 23, 2024
Primary Completion Date
October 30, 2025
Study Completion Date
April 30, 2030
ANPD001
Biologic: ANPD001 is an experimental product derived from the patient's own skin cells converted to induced pluripotent stem cells. The stem cells were differentiated into precursors for brain cells that produce dopamine.
Custom Device
A custom device to facilitate slow injection of small volumes of investigational drugs (including cell therapies), under MRI guidance
Feinstein Institutes, Manhasset
Emory University, Atlanta
University of Colorado, Aurora
University of Arizona - Banner Health, Tucson
University of California, Los Angeles, Los Angeles
Scripps Health, La Jolla
University of California, San Diego, San Diego
University of California, Irvine, Orange
University of California, San Francisco, San Francisco
Lead Sponsor
California Institute for Regenerative Medicine (CIRM)
OTHER
Aspen Neuroscience
INDUSTRY